IlluminaNCT03742037CenerimodSystemic lupus erythematosusSLE
…samples were collected at baseline and month 6. RNA sequencing (Illumina) was used to quantify gene expression. Gene set enrichment anal…
2articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT03742037 ×
NCT03742037
This institution is selected. Its supporting articles are shown below.
Articles mentioning NCT03742037
2 articles · page 1 of 1NCT03742037cenerimodautoimmune diseaseSLEsystemic lupus erythematosusLupus
…eutic benefits in autoimmune disease. The Phase 2b CARE study ( NCT03742037) evaluated the efficacy and safety of cenerimod at doses 0.5, 1…